Hany M. Fayed

506 total citations
24 papers, 307 citations indexed

About

Hany M. Fayed is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Hany M. Fayed has authored 24 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 9 papers in Pharmacology. Recurrent topics in Hany M. Fayed's work include Liver Disease Diagnosis and Treatment (12 papers), Liver physiology and pathology (10 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). Hany M. Fayed is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver physiology and pathology (10 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). Hany M. Fayed collaborates with scholars based in Egypt, Saudi Arabia and Germany. Hany M. Fayed's co-authors include Sahar S. Abd El‐Rahman, Rehab F. Abdel‐Rahman, Hanan A. Ogaly, Marawan A. Elbaset, Abeer Salama, Rania Elgohary, A. Ramadan, Sherif M. Afifi, Tuba Esatbeyoglu and Mahmoud S. Arbid and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Hany M. Fayed

18 papers receiving 306 citations

Peers

Hany M. Fayed
Zhenyu Cui China
Sidong Song China
Nashwa Abu‐Elsaad Egypt
Guangdong Tong China
Jianzhi Wu China
Mengting Yu China
Lianjun Xing China
Jianmin Qian China
Dewen Mao China
Zhenyu Cui China
Hany M. Fayed
Citations per year, relative to Hany M. Fayed Hany M. Fayed (= 1×) peers Zhenyu Cui

Countries citing papers authored by Hany M. Fayed

Since Specialization
Citations

This map shows the geographic impact of Hany M. Fayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hany M. Fayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hany M. Fayed more than expected).

Fields of papers citing papers by Hany M. Fayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hany M. Fayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hany M. Fayed. The network helps show where Hany M. Fayed may publish in the future.

Co-authorship network of co-authors of Hany M. Fayed

This figure shows the co-authorship network connecting the top 25 collaborators of Hany M. Fayed. A scholar is included among the top collaborators of Hany M. Fayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hany M. Fayed. Hany M. Fayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alsugoor, Mahdi H., Hany M. Fayed, Sherif M. Afifi, et al.. (2025). Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways. Frontiers in Pharmacology. 16. 1586231–1586231. 3 indexed citations
3.
4.
Fayed, Hany M., et al.. (2025). Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathways. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(11). 16131–16148. 3 indexed citations
5.
Kamel, Gehan M., et al.. (2025). Ertugliflozin, a SGLT-2 Inhibitor, Guards Against Thioacetamide-induced Liver Fibrosis: The Nrf2/HO-1 and TLR4/ TGF-β1 Pathways. Journal of Applied Veterinary Sciences. 0(0). 0–0.
6.
Kamel, Gehan M., et al.. (2025). Dapagliflozin alleviates thioacetamide induced-liver fibrosis in rats via controlling the Nrf2/HO-1 and TLR4/TGF-β1/PI3K signaling pathways. Immunopharmacology and Immunotoxicology. 47(3). 392–405. 2 indexed citations
7.
Elbaset, Marawan A., et al.. (2024). Nrf2/HO‐1, NF‐κB and PI3K/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats. Journal of Cellular and Molecular Medicine. 28(3). e18116–e18116. 18 indexed citations
8.
9.
Elbaset, Marawan A., et al.. (2024). Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway. Advances in Pharmacological and Pharmaceutical Sciences. 2024. 1–11. 5 indexed citations
10.
Attia, Hany G., et al.. (2023). Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches. Journal of Pharmacy & Pharmaceutical Sciences. 26. 11808–11808. 20 indexed citations
11.
Abdel‐Rahman, Rehab F., Hany M. Fayed, Azza T. Taher, et al.. (2023). Impact of Eucalyptus maculata Hook resin exudate constituents on reducing COX-2 gene expression: In-vivo anti-inflammatory, molecular docking and dynamics studies. Journal of Ethnopharmacology. 314. 116631–116631. 7 indexed citations
12.
Elbaset, Marawan A., et al.. (2023). Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2023. 1–14. 17 indexed citations
13.
Abdel‐Rahman, Rehab F., Hany M. Fayed, Marawan A. Elbaset, et al.. (2023). Apigenin role against thioacetamide-triggered liver fibrosis: Deciphering the PPARγ/TGF-β1/NF-κB and the HIF/FAK/AKT pathways. Journal of Herbmed Pharmacology. 12(2). 202–213. 16 indexed citations
14.
Elbaset, Marawan A., et al.. (2023). Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway. Scientific Reports. 13(1). 14929–14929. 13 indexed citations
15.
Shalaby, Mostafa, et al.. (2022). Rosuvastatin Restrains the Headway of Experimentally Induced Liver Fibrosis: Involvement of NF-κB and Nrf2/HO-1 Signaling Pathway. International Journal of Veterinary Science. 12(3, 2023). 366–374.
16.
17.
Abdel‐Rahman, Rehab F., Hany M. Fayed, Gihan F. Asaad, et al.. (2021). The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats. PLoS ONE. 16(12). e0260130–e0260130. 37 indexed citations
18.
Salama, Abeer, Hany M. Fayed, & Rania Elgohary. (2021). L-carnitine alleviated acute lung injuries induced by potassium dichromate in rats: involvement of Nrf2/HO-1 signaling pathway. Heliyon. 7(6). e07207–e07207. 33 indexed citations
19.
El‐Rahman, Sahar S. Abd & Hany M. Fayed. (2019). Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat. Journal of Tissue Engineering and Regenerative Medicine. 13(12). 2131–2141. 23 indexed citations
20.
Ramadan, A., Nehal A. Afifi, Nemat Yassin, et al.. (2018). Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats. Chemico-Biological Interactions. 289. 109–118. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenyu Cui Breakdown of academic impact, for papers by Sidong Song Breakdown of academic impact, for papers by Nashwa Abu‐Elsaad Breakdown of academic impact, for papers by Guangdong Tong Breakdown of academic impact, for papers by Jianzhi Wu Breakdown of academic impact, for papers by Mengting Yu Breakdown of academic impact, for papers by Lianjun Xing Breakdown of academic impact, for papers by Jianmin Qian Breakdown of academic impact, for papers by Dewen Mao
Rankless by CCL
2026